Precision Medicine

Your Annual Labs Are Missing the Point

Dr. RP, MD — Board-Certified, Emergency Medicine & Critical Care Medicine — Founder, Analog Precision Medicine

A few years ago I was eating ramen in Sapporo — eight-seat place, menu by pointing — and I felt genuinely great afterward. My colleague across the table had the exact same meal and spent the rest of the afternoon foggy and bloated.

I've seen versions of this everywhere I've traveled. Same food, same table, wildly different responses. It's one of those things that makes you appreciate how individual biology actually is — not as a concept, but as a lived daily reality that shows up in how your body handles a meal in Lyon or a street stall in Bangkok.

The standard blood panel ordered at most annual physicals is about as personalized as a population dietary guideline. It tells you whether something is acutely wrong. It doesn't tell you where your metabolic trajectory is headed, whether your cardiovascular risk is being accurately captured, or whether the slow drift happening beneath the surface will surface as a diagnosis in ten years.

Here are twelve markers that actually do that — along with an honest look at where the science holds up and where it doesn't.

The 12 Markers

Apolipoprotein B (ApoB)

Your LDL cholesterol measures the mass of cholesterol inside LDL particles. ApoB counts the particles themselves. Each atherogenic particle carries exactly one ApoB molecule, making it a direct measure of the number of things that can lodge in arterial walls. A systematic review of nine discordance studies found ApoB outperformed LDL-C as a cardiovascular risk predictor in every single comparison.[1] The National Lipid Association's 2024 expert consensus supports ApoB as the primary measure for guiding lipid-lowering therapy.[2] LDL and ApoB are discordant in somewhere between 8–23% of individuals — and in those cases, cardiovascular risk follows ApoB.

Lipoprotein(a) — Lp(a)

Roughly one in five people carry elevated Lp(a). It's almost entirely genetic — diet and statins don't move it. It's pro-inflammatory, pro-thrombotic, and independently predictive of cardiovascular events and calcific aortic valve disease. Current ACC/AHA guidelines recommend universal screening, once, because levels are stable for life.[3] If you've never been tested, you're flying partially blind on hereditary cardiovascular risk.

High-sensitivity CRP (hs-CRP)

Standard CRP is calibrated for infections and acute flares. It misses the low-grade, chronic inflammation that drives atherosclerosis. The JUPITER trial showed statin therapy significantly reduced cardiovascular events in people with elevated hs-CRP even when LDL was below standard treatment thresholds — an estimated 44% relative risk reduction.[4] One caveat worth knowing: any acute inflammation — a hard workout, a cold, a dental cleaning — temporarily spikes hs-CRP. A single abnormal result needs context; the meaningful signal is persistent elevation during clinical stability.

Fasting Insulin and HOMA-IR

Fasting glucose doesn't become abnormal until insulin resistance is already well established — often a decade into the process. Fasting insulin detects the compensation (pancreas working harder to force glucose into resistant cells) before glucose shifts. HOMA-IR (fasting glucose × fasting insulin ÷ 405) is a validated index of insulin resistance that's been in clinical use since 1985.[5] Identifying this early, when it's still fully reversible through lifestyle modification, is the whole point.

HbA1c

Most standard labs check this, but it tends to get interpreted as a pass/fail rather than a trend. An HbA1c of 5.3% and one of 5.6% are both “normal” — but they tell different metabolic stories, especially tracked over time. HbA1c also has known technical limitations: it underestimates average glucose in hemolytic conditions and can be falsely elevated in iron deficiency. Results need context.

Homocysteine

An amino acid whose accumulation in blood is associated with endothelial damage, thrombosis, and cardiovascular risk.[6] Elevation is often driven by B6, B12, or folate insufficiency — making it largely correctable. Patients with MTHFR variants are particularly prone to elevated homocysteine and benefit from specific supplementation forms. Routinely available, inexpensively tested, rarely ordered.

Vitamin D (25-OH)

Roughly 42% of U.S. adults are deficient.[7] Living in a sunny climate helps — until you factor in that most executives and office workers spend the vast majority of daylight hours indoors. The correct assay is 25-OH vitamin D, not 1,25-OH. Most longevity-oriented guidelines aim for 40–60 ng/mL as an optimal range, considerably above the standard lab lower limit of 20 ng/mL.

Ferritin

Ferritin measures iron storage — different from serum iron, and more clinically useful in most contexts. Low ferritin causes fatigue, exercise intolerance, cognitive fog, and hair thinning well before hemoglobin becomes abnormal, and is chronically under-detected in otherwise healthy women. Elevated ferritin (absent acute illness) can signal hemochromatosis, metabolic syndrome, or fatty liver disease. Both directions are informative.

TSH with Free T3 and Free T4

TSH alone reflects pituitary output, not necessarily tissue-level thyroid activity. Adding free T4 and free T3 catches discordance that TSH misses. Subclinical hypothyroidism — elevated TSH with normal T4 — independently increases LDL and cardiovascular risk.[8] TPO antibodies identify Hashimoto's thyroiditis before TSH shifts at all. This is a more complete version of what should already be standard.

10.

Uric Acid

Primarily associated with gout, but elevated uric acid is independently associated with hypertension, insulin resistance, and cardiovascular disease.[9] It reflects fructose metabolism, oxidative stress, and purine turnover — providing metabolic context that other markers don't capture. Not a top-tier independent predictor, but inexpensive, additive, and useful when the broader picture is ambiguous.

11.

SHBG and Free Testosterone

Total testosterone is largely inactive when bound to sex hormone-binding globulin. A man can have a total testosterone in the middle of the normal range with SHBG so elevated that his free testosterone is functionally low — resulting in symptoms of hypogonadism (low energy, muscle loss, cognitive changes) despite labs that look technically normal. SHBG itself is a metabolic marker: low SHBG correlates with insulin resistance; high SHBG may signal liver dysfunction or thyroid disease. Without it, total testosterone is an incomplete number.

12.

Omega-3 Index

Measures EPA and DHA incorporated into red blood cell membranes — a proxy for dietary omega-3 intake over the prior three months. An index below 4% is associated with higher cardiovascular risk in observational data; above 8% is generally considered cardioprotective.[10] I'll be direct about the limitations: large randomized trials like ASCEND found no cardiovascular benefit from standard-dose fish oil supplementation.[11] The omega-3 index is more useful as a baseline and tracking marker than as a standalone predictor of hard outcomes. It tells you whether your diet is delivering what you think it is.

Where This Science Gets Abused — and the Honest Limits

This part matters, because the biomarker optimization space has a real hype problem.

“If the answer is always ‘add a supplement,’ that's not precision medicine — it's sales.”

—

Reference ranges are not optimal ranges. They're statistical constructs — where most people fall, not where people thrive. Treating any result below the 50th percentile as a deficiency requiring a supplement protocol is not clinical medicine. It's a business model.

—

Single measurements need context. hs-CRP, ferritin, testosterone, cortisol — all of these fluctuate with illness, stress, sleep deprivation, and the time of blood draw. One abnormal value without clinical context and prior comparison points proves very little.

—

Treating the number instead of the patient is a trap. The NORVIT and HOPE-2 trials found that aggressively lowering homocysteine with B-vitamin supplementation didn't reduce cardiovascular events, even though high homocysteine correlates with increased risk.[12] Biomarkers are signals about underlying biology, not necessarily direct causal targets. The goal is to understand and address the underlying dysfunction — not collect normal numbers while the actual problem continues.

—

More testing is not automatically better. Order enough labs and you'll find values outside the optimal range in every healthy person. The clinical question is whether the finding changes management. If the answer is always 'add a supplement,' that's not precision medicine — it's sales.

These markers are most valuable when interpreted together, in clinical context, by someone who understands what each assay is actually measuring. A color-coded PDF from a consumer testing company is not that.

The Bottom Line

Your annual labs catch acute problems. They weren't designed to map your metabolic trajectory, identify cardiovascular risk building quietly over years, or give you enough information to make genuinely personalized decisions about your health.

These twelve markers do that — imperfectly, in combination, interpreted carefully. Used correctly, they turn a checkbox into an actual baseline. At Analog Precision Medicine, that baseline is where everything starts.

References

1.Sniderman AD, et al. ApoB, LDL-C, and non-HDL-C as markers of cardiovascular risk. Journal of Clinical Lipidology. 2025. doi:10.1016/j.jacl.2025.03.015
2.Soffer DE, et al. Role of apolipoprotein B in the clinical management of cardiovascular risk. Journal of Clinical Lipidology. 2024;18(5):e647–e663.
3.Grundy SM, et al. 2018 AHA/ACC Guideline on Management of Blood Cholesterol. Circulation. 2019;139(25):e1082–e1143.
4.Ridker PM, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein (JUPITER). New England Journal of Medicine. 2008;359(21):2195–2207.
5.Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function. Diabetologia. 1985;28(7):412–419.
6.Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 2015;14:6.
7.Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutrition Research. 2011;31(1):48–54.
8.Razvi S, et al. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. Journal of Clinical Endocrinology and Metabolism. 2008;93(8):2998–3007.
9.Borghi C, et al. Serum uric acid and the risk of cardiovascular and renal disease. Journal of Hypertension. 2015;33(9):1729–1741.
10.Harris WS. The omega-3 index as a risk factor for coronary heart disease. American Journal of Clinical Nutrition. 2008;87(6):1997S–2002S.
11.Bowman L, et al. Effects of n-3 fatty acid supplements in diabetes mellitus (ASCEND). New England Journal of Medicine. 2018;379(16):1540–1550.
12.Bønaa KH, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction (NORVIT). New England Journal of Medicine. 2006;354(15):1578–1588.

Dr. RP, MD is dual board-certified in Emergency Medicine and Critical Care Medicine and is the founder of Analog Precision Medicine, a precision medicine practice in Southern California. This article is for educational purposes only and does not constitute medical advice or establish a physician-patient relationship.

← Back to Blog